Korean Circ J.  2008 Jan;38(1):1-6. 10.4070/kcj.2008.38.1.1.

Prehypertension

• Hong KS

• KMID: 2225866
• DOI: http://doi.org/10.4070/kcj.2008.38.1.1

Abstract

The Seventh Report of the Joint National Committee (JNC-7) introduced a new term "prehypertension" and it broadened the range of prehypertension to 120-139/80-89 mmHg. It is estimated that 31% of the US population and 29% of the Korean population have prehypertension. This condition is very prevalent and it's associated with other cardiovascular risk factors, especially obesity and diabetes. These people are at high risk for developing hypertension and subsequent cardiovascular events. Therefore, prehypertension has become a major public health concern, but the treatment standards have not yet been established. The JNC-7 report has recommended healthy lifestyles for all the people with prehypertension and it especially advocated drug treatment for the group of people with diabetes or chronic renal disease. This article reviews the prevalence of prehypertension, the risk and rate of progression to hypertension, the associated cardiovascular disease, the adverse cardiovascular events and the current status of treatment.

Keyword

Blood pressure; Prehypertension; Prevalence

MeSH Terms

Blood Pressure
Cardiovascular Diseases
Hypertension
Joints
Life Style
Obesity
Prehypertension
Prevalence
Public Health
Renal Insufficiency, Chronic
Risk Factors

Reference

1. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003. 289:2560–2572.

2. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevevtion, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003. 42:1206–1252.

3. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997. 157:2413–2446.

4. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men. JAMA. 2002. 287:1003–1010.

5. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002. 360:1903–1913.

6. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee Guidelines: new challenges of the old problem. Arch Intern Med. 2004. 164:2126–2134.

7. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med. 2004. 164:2113–2118.

8. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit. 2005. 11:CR403–CR409.

9. Korea Institute for Health and Social Affaires. National health and nutrition examination in Korea, 2005. Ministry of Health and Welfare. 2005.

10. Hong KS, Jeong JY, Jang SN, et al. The prevalence and related risk factors of prehypertension among local residents aged 45 or over in Chuncheon city. Korean Circ J. 2006. 36:535–542.

11. Chiu YH, Wu SC, Tseng CD, Yen MF, Chen TH. Progression of pre-hypertension, stage 1 and 2 hypertension (JNC 7): a population-based study in Keelung, Taiwan (Keelung Community-based Integrated Screening No. 9). J Hypertens. 2006. 24:821–828.

12. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001. 358:1682–1686.

13. Winegarden CR. From "prehypertension" to hypertension?: additional evidence. Ann Epidemiol. 2005. 15:720–725.

14. Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006. 354:1685–1697.

15. Hong KS, Choi MG, Kim DH, et al. Rate and related factors of progression to hypertension among prehypertensive local residents aged 45 or over in Chuncheon city. Korean Circ J. 2007. 1:in press.

16. Okosun IS, Boltri JM, Anochie LK, Chandra K. Racial/ethnic differences in prehypertension in American adults: population and relative attributable risk of abdominal obesity. J Hum Hypertens. 2004. 18:849–855.

17. Tsai PS, Ke TL, Huang CJ, et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens. 2005. 23:1355–1360.

18. Cordero A, Laclaustra M, Leon M, et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. Am J Hypertens. 2006. 19:189–196.

19. Zhang Y, Lee ET, Devereux RB, et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample. Hypertension. 2006. 47:410–414.

20. Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension. 2006. 48:254–259.

21. Choi KM, Park HS, Han JH, et al. Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens. 2006. 24:1515–1521.

22. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease. Am J Hypertens. 2004. 17:568–573.

23. King DE, Egan BM, Mainous AG 3rd, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich). 2004. 6:562–568.

24. Papadopoulos DP, Makris TK, Krespi PG, et al. Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens (Greenwich). 2005. 7:729–733.

25. Toikka JO, Laine H, Ahotopa M, et al. Increased arterial intimamedia thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension. 2000. 36:929–933.

26. Ikram MK, Wittemen JC, Vingerling JR, Breteler MM, Hofman A, de Jong PT. Retinal vessel diameters and risk of hypertension. Hypertension. 2006. 47:189–194.

27. Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension. 2006. 47:962–967.

28. Liszka HA, Mainous AG 3rd, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med. 2005. 3:294–299.

29. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med. 2006. 119:133–141.

30. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001. 345:1291–1297.

31. Baldinger B, Schwarz C, Jaggy C. Cardiovascular risk factors, BMI and mortality in a cohort of Swiss males (1976-2001) with high-sum-assured life insurance cover. J Insur Med. 2006. 38:44–53.

32. Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohmmad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke. 2005. 36:1859–1863.

33. Hsia J, Margolis KL, Eaton CB, et al. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation. 2007. 115:855–860.

34. Hansen TW, Staessen JA, Zhang H, et al. Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort. Am J Hypertens. 2007. 20:483–491.

35. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure in overweight people with high normal blood pressure. Arch Intern Med. 1997. 157:657–667.

36. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003. 21:1983–1992.

37. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension. Eur Heart J. 2007. 28:1462–1536.

38. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ. 2004. 328:634–640.

39. Chockalingam A, Ganesan N, Venkatesan S, et al. Patterns and predictors of prehypertension among "healthy" urban adults in India. Angiology. 2005. 56:557–563.

40. Ramos E, Barros H. Prevalence of hypertension in 13-year-old adolescents in Porto, Portugal. Rev Port Cardiol. 2005. 24:1075–1087.

41. Seo HJ, Kim SG, Kim CS, Chang YK, Park IG. The incidence and risk factors of hypertension that developed in a male-workers' cohort for 3 years. Korean J Prev Med. 2006. 39:229–234.

42. Kanauchi M, Kanauchi K, Hashimoto T, Saito Y. Metabolic syndrome and new category 'pre-hypertension' in a Japanese population. Curr Med Res Opin. 2004. 20:1365–1370.

43. Jago R, Harrell JS, McMurray RG, Edelstein S, El Ghormli L, Bassin S. Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics. 2006. 117:2065–2073.

44. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA. 1998. 279:839–846.